A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 469,567 shares of AZN stock, worth $30.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
469,567
Previous 467,680 0.4%
Holding current value
$30.8 Million
Previous $36.5 Million 0.31%
% of portfolio
0.09%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $144,676 - $165,338
1,887 Added 0.4%
469,567 $36.6 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $31.2 Million - $37.8 Million
467,680 New
467,680 $36.5 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.